Konstantinia Sotiriadou

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND Hypofractionated adjuvant radiotherapy (RT) in breast cancer patients treated by conservative surgery has been increasingly used in recent years. We present our experience regarding tolerance/acute toxicity of a hypofractionated RT schedule. METHODS AND MATERIALS We report on 339 patients treated for 4 years (March 2003-2007) by 42.5 Gy/16(More)
CONTEXT Hypofractionated breast radiotherapy (RT), although convenient for patients and health care systems, could have a negative impact on normal tissues such as lung. AIMS To evaluate radiation-induced lung toxicity in early breast-cancer patients treated by hypofractionated RT. SETTINGS AND DESIGN We have been using the 42.5 Gy/16 fractions RT(More)
AIM To investigate the effectiveness and toxicity of radiotherapy (RT) given as 17 Gy in 2 fractions, in patients with locally advanced non-small-cell lung cancer (NSCLC) previously treated by platinum-based chemotherapy (CHT) and the impact of total tumor volume (TTV) on symptoms control. MATERIALS AND METHODS Patients with inoperable NSCLC resistant to(More)
  • 1